James Edgemond United Therapeutics Corp (UTHR) insider trading activity

UTHR Quotes by TradingView

James Edgemond is CFO AND TREASURER of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 8,142 shares of UTHR, which is worth approximately $3.8 Million. The most recent transaction as insider was on Nov 24, 2025, when has been sold 21,000 shares (Common Stock) at a price of $474.88 per share, resulting in proceeds of $9,972,480. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.14K
0.3% 3M change
0.92% 12M change
Total Value Held $3.8 Million

JAMES EDGEMOND Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 24 2025
SELL
Open market or private sale
$9,972,480 $474.88 p/Share
21,000 Reduced 72.06%
8,142 Common Stock
Nov 24 2025
BUY
Exercise of conversion of derivative security
$3,066,630 $146.03 p/Share
21,000 Added 41.88%
29,142 Common Stock
Nov 17 2025
SELL
Open market or private sale
$9,895,410 $471.21 p/Share
21,000 Reduced 72.12%
8,118 Common Stock
Nov 17 2025
BUY
Exercise of conversion of derivative security
$3,066,630 $146.03 p/Share
21,000 Added 53.26%
18,430 Common Stock
Nov 10 2025
SELL
Open market or private sale
$9,473,520 $451.12 p/Share
21,000 Reduced 72.12%
8,118 Common Stock
Nov 10 2025
BUY
Exercise of conversion of derivative security
$3,066,630 $146.03 p/Share
21,000 Added 41.9%
29,118 Common Stock
Nov 04 2025
SELL
Open market or private sale
$9,151,380 $435.78 p/Share
21,000 Reduced 72.12%
8,118 Common Stock
Nov 04 2025
BUY
Exercise of conversion of derivative security
$3,066,630 $146.03 p/Share
21,000 Added 41.9%
29,118 Common Stock
Jun 09 2025
SELL
Open market or private sale
$3,917,519 $326.46 p/Share
12,000 Reduced 59.65%
8,118 Common Stock
Jun 09 2025
BUY
Exercise of conversion of derivative security
$1,413,120 $117.76 p/Share
12,000 Added 37.36%
20,118 Common Stock
Jun 02 2025
SELL
Open market or private sale
$3,911,400 $325.95 p/Share
12,000 Reduced 59.65%
8,118 Common Stock
Jun 02 2025
BUY
Exercise of conversion of derivative security
$1,413,120 $117.76 p/Share
12,000 Added 37.36%
20,118 Common Stock
Nov 04 2024
SELL
Open market or private sale
$2,909,127 $374.02 p/Share
7,778 Reduced 49.08%
8,068 Common Stock
Nov 04 2024
BUY
Exercise of conversion of derivative security
$991,829 $119.01 p/Share
8,334 Added 49.12%
8,633 Common Stock
Oct 28 2024
SELL
Open market or private sale
$2,730,000 $350.0 p/Share
7,800 Reduced 50.94%
7,512 Common Stock
Oct 28 2024
BUY
Exercise of conversion of derivative security
$991,829 $119.01 p/Share
8,334 Added 50.75%
8,088 Common Stock
Oct 21 2024
SELL
Open market or private sale
$2,855,916 $366.99 p/Share
7,782 Reduced 52.72%
6,978 Common Stock
Oct 21 2024
BUY
Exercise of conversion of derivative security
$991,829 $119.01 p/Share
8,334 Added 52.48%
7,545 Common Stock
Oct 14 2024
SELL
Open market or private sale
$2,773,016 $355.88 p/Share
7,792 Reduced 54.8%
6,426 Common Stock
Oct 14 2024
BUY
Exercise of conversion of derivative security
$1,116,839 $134.01 p/Share
8,334 Added 54.36%
6,998 Common Stock
Oct 07 2024
SELL
Open market or private sale
$2,771,078 $355.54 p/Share
7,794 Reduced 56.98%
5,884 Common Stock
Oct 07 2024
BUY
Exercise of conversion of derivative security
$991,829 $119.01 p/Share
8,334 Added 56.35%
6,457 Common Stock
Sep 30 2024
SELL
Open market or private sale
$2,794,367 $358.62 p/Share
7,792 Reduced 59.32%
5,344 Common Stock
Sep 30 2024
BUY
Exercise of conversion of derivative security
$991,829 $119.01 p/Share
8,334 Added 58.48%
5,916 Common Stock
Sep 23 2024
SELL
Open market or private sale
$2,760,095 $354.04 p/Share
7,796 Reduced 61.88%
4,802 Common Stock
JE

James Edgemond

CFO AND TREASURER
Silver Spring, MD

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on UTHR